Literature DB >> 24169650

Long-term outcome of primary endoresection of choroidal melanoma.

Lazaros Konstantinidis1, Carl Groenewald, Sarah E Coupland, Bertil Damato.   

Abstract

BACKGROUND: Endoresection of choroidal melanoma may offer the best hope of conserving vision in some patients but is controversial because of concerns regarding iatrogenic tumour dissemination.
METHODS: Retrospective, non-randomised study of consecutive patients who underwent endoresection for choroidal melanoma at the Liverpool Ocular Oncology Centre between 1996 and 2010.
RESULTS: The study included 71 patients with a mean age of 58.7 years. The tumour extended within 2 disc diameters of the optic disc in 46 (65%) eyes, involving the disc in 24 (34%) eyes. The mean largest basal tumour diameter and tumour thickness were 9.5 mm and 4.4 mm, respectively. The median follow-up was 4.1 years. The visual acuity at the latest follow-up was better than 6/30 in 31% eyes. The main causes of visual loss were foveal excision, rhegmatogenous retinal detachment (RD) and proliferative vitreo-retinopathy (PVR). Local recurrence developed in two patients (3%), who were treated by enucleation and proton beam radiotherapy, respectively. RD occurred in 16 cases (22%). Three (4%) eyes were enucleated, two because of PVR and one because of local tumour recurrence. Five patients died of metastatic disease.
CONCLUSIONS: Endoresection achieved high rates of local tumour control. This operation would seem to be a useful alternative to radiotherapy as a means of conserving vision in eyes with juxtapapillary melanoma.

Entities:  

Keywords:  Choroid; Neoplasia; Treatment Surgery

Mesh:

Year:  2013        PMID: 24169650     DOI: 10.1136/bjophthalmol-2013-304022

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Egress of large quantities of heavy liquids from exposed choroid: a route for possible tumor dissemination via vortex veins in endoresection of choroidal melanoma.

Authors:  A M Joussen; D Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-10       Impact factor: 3.117

2.  Core Endoresection as Neoadjuvant Treatment of Uveal Melanoma.

Authors:  Iwona Rospond-Kubiak; Carl Groenewald; Sarah E Coupland; Bertil Damato
Journal:  Ocul Oncol Pathol       Date:  2015-09-24

Review 3.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

4.  Secondary endoresection for previously treated choroidal melanomas with a non-responsive course and persistent exudative retinal detachment.

Authors:  Ahmet Kaan Gündüz; Ibadulla Mirzayev
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

5.  Fatal Air Embolism after Choroidal Melanoma Endoresection without Air Infusion: A Case Report.

Authors:  Duangnate Rojanaporn; Boontip Tipsuriyaporn; Patnarin Chulalaksiriboon; Tanit Virankabutra; Sunthiti Morakul; Bertil Damato
Journal:  Ocul Oncol Pathol       Date:  2021-08-13

6.  Safe endoresection.

Authors:  Michael I Seider; Bertil E Damato
Journal:  Indian J Ophthalmol       Date:  2014-12       Impact factor: 1.848

7.  Outcomes of primary endoresection for choroidal melanoma.

Authors:  Andre A C Vidoris; Andre Maia; Marcia Lowen; Melina Morales; Jordan Isenberg; Bruno F Fernandes; Rubens N Belfort
Journal:  Int J Retina Vitreous       Date:  2017-11-06

Review 8.  Choroidal Melanoma Resection.

Authors:  Hany S Hamza; Abdelrahman M Elhusseiny
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Apr-Jun

Review 9.  Uveal Melanoma in Asians: A Review.

Authors:  Pradeep Manchegowda; Arun D Singh; Carol Shields; Swathi Kaliki; Parag Shah; Lingam Gopal; Pukhraj Rishi
Journal:  Ocul Oncol Pathol       Date:  2021-02-09

Review 10.  Choroidal melanoma: A short review with an Indian perspective.

Authors:  Bikramjit P Pal; Saili Garge; Vikas Khetan
Journal:  Oman J Ophthalmol       Date:  2017 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.